SMS Pharmaceuticals IPO GMP History
SMS Pharmaceuticals IPO has been listed on February 28, 2007 at a listing price of ₹360, against the issue price of ₹380 — a loss of ₹20 (-5.26%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
SMS Pharmaceuticals IPO raised ₹98.01 Cr. through its IPO at a price band of ₹360 to ₹380 per share, with a lot size of 15 shares. The IPO was open for subscription from 05 Feb 2007 to 08 Feb 2007.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 12 Nov, 8:15 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| No GMP history available yet. | |||||
SMS Pharmaceuticals IPO dates
Key dates from opening to listing. Today is 12 November.
- Open 05 Feb 2007
- Close 08 Feb 2007
- Allotment TBA
- Refund/credit TBA
- Listing 28 Feb 2007
SMS Pharmaceuticals IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹380 |
|---|---|
| Listing gain / loss | −₹20 per share |
| Listing date | 28 Feb, 2007 |
| Actual listing price | ₹360 (-5.26%) |
Is SMS Pharmaceuticals IPO GMP reliable?
Grey market premium for SMS Pharmaceuticals IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the SMS Pharmaceuticals IPO full review for a fundamentals-based assessment before making any grey market trades.
SMS Pharmaceuticals IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for SMS Pharmaceuticals IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About SMS Pharmaceuticals IPO
SMS Pharmaceuticals Limited makes active pharmaceutical ingredients and pharmaceutical intermediates. Its promoters include Ramesh Babu Potluri, T. V. V. S. N. Murthy, Hima Bindu Potluri and Annapurna Talluri.
Its bulk drugs included Ranitidine HCl, Sumatriptan Succinate, Sildenafil Citrate, Omeprazole Magnesium, Ramipril, Almotriptan, Gemcitabine and Imatinib Mesilate and their intermediates. It also did contract research with SPECS of the Netherlands.
It had an installed capacity of approximately 1440 MTPA and 625 employees as on 30 November 2006, of whom 330 were permanent.
The IPO was Rs 98.01 crore and was entirely a fresh issue at Rs 380, the top of the Rs 360 to Rs 380 band.
Frequently asked
What is the GMP of SMS Pharmaceuticals IPO?
The current Grey Market Premium (GMP) of SMS Pharmaceuticals IPO is not yet started or active in the market.
What is the Kostak Price of SMS Pharmaceuticals IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for SMS Pharmaceuticals IPO is not available.
What is the Subject to Sauda Price of SMS Pharmaceuticals IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of SMS Pharmaceuticals IPO?
SMS Pharmaceuticals IPO listed on February 28, 2007 at ₹360, against the issue price of ₹380 — a loss of -5.26%.
How did the GMP of SMS Pharmaceuticals IPO trend before listing?
The GMP of SMS Pharmaceuticals IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.
Explore SMS Pharmaceuticals IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
